Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review.

Saved in:
Bibliographic Details
Title: Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review.
Authors: Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo 105-8461, Japan., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, Medical University of Silesia, 41-800 Zabrze, Poland., Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia., Kawada T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan., Bekku K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, 119435 Moscow, Russia., Deimling MV; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany., Chlosta M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Clinic of Urology and Urological Oncology, Jagiellonian University, 30-688 Krakow, Poland., Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC H2X 0A9, Canada., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo 105-8461, Japan., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Wahringer Gurtel 43 18-20, 1090 Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, 119435 Moscow, Russia.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman 19328, Jordan.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Urology, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic.; Department of Urology, Weill Cornell Medical College, New York, NY 10021, USA.; Karl Landsteiner Institute of Urology and Andrology, 1090 Vienna, Austria.
Source: Journal of personalized medicine [J Pers Med] 2023 Apr 07; Vol. 13 (4). Date of Electronic Publication: 2023 Apr 07.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2075-4426
DOI:10.3390/jpm13040641